Recently, Collin de l ́Hortet et al. [22] described involvement of reduced GH/epidermal growth factor receptor (EGFR) signaling in diminished liver regeneration capacity in hepatic steatosis which was partly resolved by GH administration. The gene discussed is EGFR; the disease is fatty liver disease.